TAK

21.8552.08%
SI

Seigo Izumo

Chair of Management Board

Dr. Seigo Izumo, MD, serves as the Chair of Management Board, Head of Scientific Affairs, Japan and Global Head of Regenerative Medicine Unit at Takeda Pharmaceutical Company Limited. Dr. Izumo served as Senior Vice President of Cardiovascular Therapeutics for Gilead Sciences, Inc. since September 2008. He oversaw Gilead's growing cardiovascular business unit. He served as Vice President & Global Head of Cardiovascular Research at Novartis Institutes for BioMedical Research. Prior to joining Novartis in July 2003, he served as Professor of Medicine at Harvard Medical School in Boston and at Harvard-MIT Division of Health Sciences and Technology. Along with his academic position at Harvard, he served as Director of Cardiovascular Research and Physician, Department of Medicine, Beth Israel Deaconess Medical Center, Boston and Director of the CardioGenomics Program, a National, Heart Lung and Blood Institute-sponsored initiative. He served as the Chief of the Cardiology Division and Professor of Internal Medicine and Biological Chemistry, University of Michigan Medical School in Ann Arbor. He received his Undergraduate and Medical Degrees from the University of Tokyo.

Positions